Browse all categories:

DMT and Ayahuasca Student Educational Slides

Ayahuasca has been used as a medicine in Mesoamerican ceremonies for thousands of years, but the primary psychoactive compound, DMT, was not synthesised until 1931. DMT was studied during the wave of psychedelic research in the 1950s and 60s until research was banned in 1971 by the Convention of Psychotropic Substances. Ayahuasca was not included  …


‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology

Objective Identify a coherent nomenclature for Cannabis sativa L. derived products and their analogues.   Design Research undertaken in parallel to the three-year assessment of Cannabis derivatives by the World Health Organisation. The scope is limited to Cannabis products intended for human incorporation (internal and topical consumption). Primarily embedded in pharmacognosy, the study incorporates a  …


Ending the pain of children with severe epilepsy?

An audit of the impact of medical cannabis in 10 patients with severe epilepsy. Background Scientific and anecdotal evidence suggest that whole-plant cannabis extracts are effective in reducing seizure frequency in individuals with a range of epileptic etiologies. We report a case series of 10 individuals using CBMPs in the UK to treat their conditions.  …


End of year update - 2020

There is little doubt that this last year has been a hugely turbulent one for everyone. At Project Twenty21, we have remained innately focused on delivering our objectives of improving access of medical cannabis for patients, and collecting a substantial evidence base on the efficacy and safety profile of medical cannabis across a range of  …


Harm Reduction in Public Policy - the UK and the US – A DrugScience evening reception at the House of Lords

On Wednesday 30 May 2018, DrugScience hosted an evening reception at the House of Lords, in partnership with Harm Reduction International. Sponsored by DrugScience trustee Lord Nick Rea, the evening featured presentations on the latest strategic approaches to reduce the negative consequences associated with risk behaviours and addiction, the challenging global funding environment for harm  …

Better late than never? After 82 years the WHO reviews cannabis!

The WHO is the world’s leading health organisation guiding governments around the world. So we expect their advice to be up to date and evidence-based, particularly on controversial topics. One of the most controversial topics of our time is the international community’s approach to drug policy, particularly that relating to the most popular so-called “illegal”  …

New Zealand revises sentencing framework for methamphetamine offences

Dr James Foulds, Consultant forensic psychiatrist, Christchurch New Zealand Methamphetamine smoking is the commonest form of stimulant use in New Zealand. Asian importation has increased recently, and the drug has got much cheaper. However, despite harsh sanctions, dealing remains attractive for many people- including those who sell the drug to fund their own use. Until  …


Looking back on the establishment of Drug Science

I first came across David Nutt in July 2007, when he spoke at a conference called ‘Criminal Justice and Social Justice’, which the Centre for Crime and Justice Studies held at King’s College London. David spoke on the subject of ‘Why adopt a harm approach in relation to drugs?’. Here was someone, I thought at  …


NICE on cannabidiol for childhood epilepsy

At the end of last week, NICE released their initial appraisal on cannabidiol in the form of Epidiolex for childhood epilepsy.  As predicted by Drug Science experts they found against it on the grounds of cost-benefit. We don’t have the company submission regarding cost/benefit analysis, and consequently cannot comment on those, but we can reflect  …


Press Release: Government decision on cannabis-related medicinal products draws criticism from independent scientific body, Drug Science.

Today (13th August 2019), the independent scientific body Drug Science has responded with disappointment to a decision by the National Institute for Health and Care Excellence (NICE), relating to cannabis-related medical products. In November 2018, the then Home Secretary Sajid Javid introduced regulations so that cannabis-derived medicinal products would be available on prescription. This change  …